SCHEMBL21089314

SCHEMBL21089314

Cc1ccc(C)c(-c2cc(-c3cccc4c3oc3ccccc34)c3nc(-c4ccccc4O)sc3c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.41
GLA P06280 2/20 0.34
PDCD1 Q15116 1/20 0.34
CD274 Q9NZQ7 1/20 0.34
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
MAPT P10636 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
KDM4E B2RXH2 1/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
HTR2B P41595 1/20 0.32
PTPRF P10586 1/20 0.32
PTPN2 P17706 1/20 0.32
PTPN1 P18031 1/20 0.32
PIK3CD O00329 1/20 0.31
PIK3CB P42338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21089317 0.90 KDM4E (0.35) ALOX5GLAPDCD1CD274MAOB
SCHEMBL21089461 0.90 ALOX5 (0.50) ALOX5MAOAMAPTMEN1KMT2A
SCHEMBL21089269 0.87 ALOX5 (0.46) ALOX5MAOAMAPTMEN1KMT2A
SCHEMBL21089678 0.86 PDCD1 (0.38) PDCD1CD274MAOAMAOBMAPT
SCHEMBL21089316 0.85 ALOX5 (0.47) ALOX5MAOAMAPTMEN1KMT2A
SCHEMBL21089399 0.84 ALOX5 (0.45) ALOX5PDCD1CD274MAOAMAPT
SCHEMBL21089197 0.84 ALOX5 (0.48) ALOX5PDCD1CD274MAOAMAPT
SCHEMBL21089211 0.83 ALOX5 (0.47) ALOX5MAOAMAPTMEN1KMT2A
SCHEMBL21089493 0.82 ALOX5 (0.45) ALOX5MAOAMAPTMEN1KMT2A
SCHEMBL21089675 0.81 PDCD1 (0.44) ALOX5PDCD1CD274MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11569461-B2 Organic electroluminescence device and organometallic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-01-31 US disclosed
US-20190181358-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE LAPTO CO., LTD. (KR) 2019-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11569461-B2 Organic electroluminescence device and organometallic compound for organic electroluminescence device CHRM1, L1CAM, CHRM4 ALOX5 4229/4885GLA 3602/4885PDCD1 1149/4885
US-20190181358-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE CHRM1, L1CAM, CHRM4 ALOX5 4229/4885GLA 3602/4885PDCD1 1149/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.